NCT01773187 2020-09-29Pacritinib Versus Best Available Therapy to Treat MyelofibrosisCTI BioPharmaPhase 3 Terminated327 enrolled 11 charts
NCT01998828 2020-04-20Safety and Efficacy of Momelotinib in Subjects With Polycythemia Vera or Essential ThrombocythemiaSierra Oncology LLC - a GSK companyPhase 2 Terminated39 enrolled
NCT01650805 2014-11-17Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)Ariad PharmaceuticalsPhase 3 Terminated307 enrolled 11 charts